NCT03754023View on ClinicalTrials.gov

Biomarker Rule in/Out in Patients With Acute Diseases for Validation of AKI (BRAVA) Acute Kidney Injury

CompletedOBSERVATIONAL

Enrollment

818

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

November 30, 2019

Conditions

Acute Kidney Injury

Interventions

DIAGNOSTIC_TEST

Urine-TIMP-IGFBP7 biomarker for AKI

Trial Locations (5)

10400

Rhamathibody Hospital, Bangkok

119074

National University Hospital, Singapore

500003

Yashoda Hospital, Hyderabad

NSW2031

Prince of Wales Hospital, Sydney

05030

Konkuk University Medical Center, Seoul

All Listed Sponsors

lead

GREAT Network Italy

NETWORK

NCT03754023 - Biomarker Rule in/Out in Patients With Acute Diseases for Validation of AKI (BRAVA) Acute Kidney Injury | Biotech Hunter | Biotech Hunter